Bath & Body WorksWBO:LBRA +4.71%62 EBITDA Margin % is 21.48% as of Apr. 2026, which is 1% below its 10-year median of 21.68. GuruFocus rates WBO:LBRA with a GF Score™ of 62/100 and a GF Value™ of €29.07 (Significantly Undervalued). The stock has 4 warning signs investors should review. Among 1,128 Retail - Cyclical companies, Bath & Body Works ranks better than 84.66% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Bath & Body Works's EBITDA for the
three
months ended in Apr. 2026 was €253 Mil. Bath & Body Works's Revenue for the
three
months ended in Apr. 2026 was €1,178 Mil. Therefore, Bath & Body Works's EBITDA margin for the quarter that ended in Apr. 2026 was 21.48%.
Bath & Body Works (WBO:LBRA) EBITDA Margin % Explanation
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Bath & Body Works EBITDA Margin % Related Terms
Bath & Body Works EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Bath & Body Works's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
WBO:LBRA vs MNSO, ASO, RH: EBITDA Margin % Comparison
For the Specialty Retail subindustry, Bath & Body Works's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Bath & Body Works EBITDA Margin % vs Retail - Cyclical Industry
For the Retail - Cyclical industry and Consumer Cyclical sector, Bath & Body Works's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Bath & Body Works's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Bath & Body Works (WBO:LBRA) has a EBITDA Margin % of 21.48% as of Apr. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bath & Body Works and its competitors. This is near median its historical median of 21.68. Over the past decade, Bath & Body Works' EBITDA Margin % has ranged from 13.84 to 32.25. According to the industry distribution chart, Bath & Body Works ranks #173 out of 1128 companies in the Retail - Cyclical industry, placing it in the top 15.3%.
Is Bath & Body Works' EBITDA Margin % too high?
Bath & Body Works' current EBITDA Margin % of 21.48% is near median its 10-year median of 21.68. Over the past 10 years, this metric has ranged from a low of 13.84 to a high of 32.25. The Retail - Cyclical industry median EBITDA Margin % is 7.48. Bath & Body Works' value of 21.48% is 187.2% above this industry median. Based on the distribution chart, Bath & Body Works ranks #173 out of 1128 companies in the Retail - Cyclical industry, which is in the top quartile — a strong position relative to peers. Overall, Bath & Body Works has a GF Score™ of 62/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Bath & Body Works' EBITDA Margin % compare to MNSO and ASO?
According to the Retail - Cyclical industry distribution chart, Bath & Body Works ranks #173 out of 1128 companies for EBITDA Margin %. This places Bath & Body Works in the top 15% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 7.48. Bath & Body Works' value of 21.48% is 187.2% above this benchmark. Historically, Bath & Body Works' own EBITDA Margin % has ranged from 13.84 to 32.25 over the past decade. While the company's 10-year median is 21.68 vs. the industry median of 7.48, Bath & Body Works has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Retail - Cyclical company?
The median EBITDA Margin % among Retail - Cyclical companies is 7.48, based on 1,128 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Bath & Body Works's current EBITDA Margin % of 21.48% is 187.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Bath & Body Works and its competitors. For the Retail - Cyclical industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Bath & Body Works's current EBITDA Margin % is 21.48%, which is near median its own 10-year median of 21.68. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bath & Body Works stock overvalued right now?
Based on GuruFocus' analysis, Bath & Body Works (WBO:LBRA) is currently considered Significantly Undervalued. The stock's GF Value™ is €29.07, compared to a current price of €18.91 — trading 35% below its estimated fair value. The current EBITDA Margin % is 21.48%, which is near median its 10-year median of 21.68 and 187.2% above the Retail - Cyclical industry median of 7.48. Bath & Body Works' overall GF Score™ is 62/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Bath & Body Works (WBO:LBRA), the current EBITDA Margin % is 21.48% as of Apr. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Bath & Body Works (WBO:LBRA) Overvalued in 2026?
Based on GuruFocus' analysis, Bath & Body Works stock appears to be undervalued.
The current stock price of €18.91 is trading 35% below its estimated GF Value™ of €29.07.
GuruFocus considers Bath & Body Works to be Significantly Undervalued.
Key valuation signals for WBO:LBRA:
EBITDA Margin %: 21.48% (near median its 10-year median of 21.68)
GF Value™: €29.07 vs. price of €18.91 (35% below fair value)
Industry Position: 187.2% above the Retail - Cyclical median (#173 of 1128)
No single metric tells the full story. See the WBO:LBRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Bath & Body Works is a specialty home fragrance and fragrant body care retailer operating under the Bath & Body Works, C.O. Bigelow, and White Barn brands. The company generates most of its business in North America, with just 4% of sales from international markets in fiscal 2025. For fiscal 2025, 77% of sales stemmed from the brick-and-mortar network of more than 1,900 retail stores, similar to 2024 levels, as consumer shopping patterns remained normal. Future growth is expected from store upgrades, digital and international channels, as well as adjacent category expansions like men's and lip.
62GF Score
Get the complete analysis for WBO:LBRA
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
WBO:LBRA has been successfully added to your 
